SIGA Technologies Company Profile (NASDAQ:SIGA)

About SIGA Technologies (NASDAQ:SIGA)

SIGA Technologies logoSIGA Technologies, Inc. is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company's lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). TPOXX is an investigational product that is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. The Company relies on and uses third parties known as contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company identified a lead pre-clinical drug candidate with activity against four serotypes of the virus and which has shown efficacy in a murine model of disease.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:SIGA
  • CUSIP: 82691710
  • Web:
  • Market Cap: $244.22 million
  • Outstanding Shares: 54,164,000
Average Prices:
  • 50 Day Moving Avg: $3.25
  • 200 Day Moving Avg: $3.23
  • 52 Week Range: $1.90 - $3.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 3.78
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $18.92 million
  • Price / Sales: 8.87
  • Book Value: ($3.76) per share
  • Price / Book: -0.82
  • EBIDTA: ($19,310,000.00)
  • Net Margins: -165.62%
  • Return on Assets: -21.48%
  • Average Volume: 37,219 shs.
  • Short Ratio: 9.46
Frequently Asked Questions for SIGA Technologies (NASDAQ:SIGA)

What is SIGA Technologies' stock symbol?

SIGA Technologies trades on the NASDAQ under the ticker symbol "SIGA."

How were SIGA Technologies' earnings last quarter?

SIGA Technologies, Inc. (NASDAQ:SIGA) posted its quarterly earnings results on Thursday, May, 1st. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of $0.22 by $0.28. The firm earned $0.55 million during the quarter, compared to the consensus estimate of $26.50 million. View SIGA Technologies' Earnings History.

Who are some of SIGA Technologies' key competitors?

Who are SIGA Technologies' key executives?

SIGA Technologies' management team includes the folowing people:

  • Eric A. Rose M.D., Executive Chairman of the Board
  • Phillip Louis Gomez III, Chief Executive Officer, Director
  • Daniel J. Luckshire, Chief Financial Officer, Executive Vice President, Secretary
  • Dennis E. Hruby Ph.D., Chief Scientific Officer, Vice President
  • James J. Antal CPA, Independent Director
  • Michael Jonathan Bayer, Independent Director
  • Thomas E. Constance, Independent Director
  • Jeffrey B. Kindler, Independent Director
  • Joseph W. Marshall III, Independent Director

How do I buy SIGA Technologies stock?

Shares of SIGA Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SIGA Technologies' stock price today?

One share of SIGA Technologies stock can currently be purchased for approximately $3.10.

MarketBeat Community Rating for SIGA Technologies (NASDAQ SIGA)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  46
MarketBeat's community ratings are surveys of what our community members think about SIGA Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for SIGA Technologies (NASDAQ:SIGA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SIGA Technologies (NASDAQ:SIGA)
No equities research coverage for this company has been tracked by


Earnings History for SIGA Technologies (NASDAQ:SIGA)
Earnings by Quarter for SIGA Technologies (NASDAQ:SIGA)
Earnings History by Quarter for SIGA Technologies (NASDAQ SIGA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2014Q1$0.22($0.06)$26.50 million$0.55 millionViewListenView Earnings Details
3/10/2014Q413($0.08)$2.50 million$0.90 millionViewN/AView Earnings Details
11/6/2013Q313($0.09)$69.00 millionViewN/AView Earnings Details
3/6/2013Q4 2012($0.07)($0.06)$5.00 million$2.50 millionViewN/AView Earnings Details
11/5/2012Q312$0.11($0.06)$3.60 million$2.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for SIGA Technologies (NASDAQ:SIGA)
Current Year EPS Consensus Estimate: $1.03 EPS
Next Year EPS Consensus Estimate: $0.82 EPS


Dividend History for SIGA Technologies (NASDAQ:SIGA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for SIGA Technologies (NASDAQ:SIGA)
Insider Trades by Quarter for SIGA Technologies (NASDAQ:SIGA)
Insider Trades by Quarter for SIGA Technologies (NASDAQ:SIGA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/7/2014& Forbes Holdings I MacandrewsDirectorBuy199,727$1.50$299,590.50View SEC Filing  
9/26/2014Bruce SlovinDirectorSell25,000$1.35$33,750.00View SEC Filing  
9/24/2014& Forbes Holdings I MacandrewsDirectorBuy204,157$1.34$273,570.38View SEC Filing  
9/23/2014& Forbes Holdings I MacandrewsDirectorBuy151,158$1.33$201,040.14View SEC Filing  
9/17/2013Michael BayerDirectorBuy15,000$3.58$53,700.00View SEC Filing  
9/13/2013Michael BayerDirectorSell15,000$3.55$53,250.00View SEC Filing  
5/30/2013Bruce SlovinDirectorSell15,000$3.83$57,450.00View SEC Filing  
5/24/2013Joseph W Marshall IIIDirectorBuy7,000$3.59$25,130.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for SIGA Technologies (NASDAQ:SIGA)
Latest Headlines for SIGA Technologies (NASDAQ:SIGA)
DateHeadline logoSIGA Technologies (SIGA) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow - June 12 at 7:17 PM logoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017 - June 9 at 8:04 PM logoSIGA Technologies (SIGA) Given News Sentiment Score of 0.31 - April 26 at 8:00 PM logoFavorable Media Coverage Extremely Likely to Affect SIGA Technologies (SIGA) Stock Price - April 22 at 8:31 AM logoSIGA Completes Enrollment and Dosing in Final Cohort of Phase I Study of IV Formulation of TPOXX® (tecovirimat) to Treat Smallpox - April 20 at 8:13 AM logoSIGA TECHNOLOGIES INC Files SEC form 10-K, Annual Report - March 7 at 7:42 PM logoForm 8-K SIGA TECHNOLOGIES INC For: Dec 22 - December 23 at 7:58 PM logoSIGA TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. o - December 13 at 8:17 PM logoSIGA TECHNOLOGIES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal - November 18 at 7:03 PM logoSIGA Technologies (SIGA) Announces Completion of $35.3M Rights Offering - November 16 at 7:45 PM logoSIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation - November 16 at 7:45 PM logoSIGA TECHNOLOGIES INC Financials - November 9 at 7:30 PM logoSIGA TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report - November 2 at 7:47 PM logoSIGA TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - October 21 at 7:21 PM logoSIGA TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec - October 19 at 7:58 PM logoSIGA TECHNOLOGIES INC Files SEC form 8-K, Other Events - October 6 at 7:01 PM logoSIGA Technologies (SIGA) Says Bankruptcy Court Approves Transaction to Pay PharmAthene Claim in Full - September 22 at 6:58 PM logoSIGA TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial - September 7 at 7:25 PM logo5:41 pm SIGA Technologies announces DSMB approval to complete subject enrollment in the final cohort of Phase III Study of TPOXX (tecovirimat); actions achieve critical BARDA milestone; company now eligible for $20.5 million payment - August 8 at 7:37 PM logoSIGA TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principa - August 2 at 7:45 PM



SIGA Technologies (SIGA) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff